prevalence

Prevalence of disease for NMOSD estimated at 22,000 US patients

A new study of disease prevalence estimates that about 22,000 people in the U.S. were living with neuromyelitis optica spectrum disorder (NMOSD) in 2022. The findings also suggest that the progressive autoimmune disease is most common in Black women, as compared with other U.S. demographics. For Asian American women,…

ACTRIMS 2023: NMOSD affects 3 times more women than men in US

The annual prevalence of neuromyelitis optica spectrum disorder (NMOSD) in the U.S. is considerably higher than previously estimated, affecting about nine out of every 100,000 people, according to a study that analyzed 2021 electronic health records. The data also showed that the disease is more than twice as common…